COPD — all decisions

The Board remands the claims for service connection for COPD, lung cancer, and sinusitis to obtain additional medical opinions.

The Board denied the veteran's claims for increased ratings and remanded several service connection claims due to missing or unassociated private medical records.

The Board granted an effective date of May 27, 2021, for the award of separate ratings for right and left lower extremity radiculopathy but denied an earlier effective date for service connection for GERD. The TDIU claim was also denied.

The Board granted service connection for a respiratory disability, to include COPD and bronchitis, based on the Veteran's in-service participation in toxic exposure risk activities.

The Board granted service connection for unspecified anxiety disorder with major depression, pituitary microadenoma benign neoplasm with migraine headaches, and asthma with chronic obstructive pulmonary disease (COPD), with assigned ratings of 70%, 50%, and 30% respectively. The claims for other conditions were remanded.

The appeal for service connection and rating issues related to left ankle arthritis, bilateral plantar fasciitis, COPD, and bilateral calcaneal spurs was dismissed due to untimely submission of the Notice of Disagreement.

The Veteran's service-connected migraines were granted a rating of 50 percent, the maximum schedular rating, and an earlier effective date of July 24, 2020, was granted for this increased rating.

The Board remands the claims for service connection for various conditions, including bilateral hearing loss, tinnitus, low back condition, COPD, brain condition, diabetes mellitus type II, GERD, heart condition, and hypertension, to obtain additional evidence.

The Board granted service connection for a back disability and a respiratory disability, including COPD and asthma, as secondary to the service-connected tuberculosis with lobectomy. The claims for a heart disability, diabetes mellitus, and kidney disability were remanded.

The Board remands the issues of service connection for sleep apnea, an initial compensable rating for chronic obstructive pulmonary disease (COPD), and a total rating based on individual unemployability due to service-connected disabilities.

The Board denied service connection for anemia and a respiratory disorder, including asthma, emphysema, and COPD, as the conditions were not related to in-service exposures.

The Board denied the veteran's claim for service connection for chronic obstructive pulmonary disease (COPD), finding that there was no evidence of a nexus between the COPD and his in-service asbestos exposure or other toxic substances.

The appeal regarding the proposed reduction of the Veteran's disability rating for asthma with chronic bronchitis and COPD is dismissed because the February 2024 decision was not a final determination by the VA.

The Board remands the appeal to obtain an adequate nexus opinion from a non-VA, independent medical expert in the field of pulmonology.

The Board granted an initial 100 percent rating for COPD with asthma and service connection for tinnitus, but remanded the claim for bilateral hearing loss.

The Board remands the claim for service connection for breathing impairment to include COPD and emphysema, secondary to asbestos exposure, due to a pre-decisional duty to assist error.

The Board denied increased ratings for PTSD and hypertension, but remanded the claim for service connection of chronic obstructive pulmonary disease (COPD).

The Veteran withdrew his appeal for service connection for constrictive bronchiolitis/COPD, and the Board has no jurisdiction to review this issue.

The appeal for service connection for heart disease was dismissed, and the claims for erectile dysfunction, sleep apnea, lumbar spine degenerative disc disease, and COPD were denied. The claim for chronic hip pain was remanded.

The Board remands the Veteran's claim for service connection for chronic pulmonary disease (COPD) to obtain an addendum medical opinion regarding whether the COPD was aggravated by his service-connected asthma.